Filters
Other countries
Tests names and labs | Conditions | Genes, analytes, and microbes | Methods |
---|---|---|---|
Invitae Expanded Renal Disease Panel Labcorp Genetics (formerly Invitae) LabCorp United States | 693 | 388 |
|
Centogene AG - the Rare Disease Company Germany | 218 | 135 |
|
HNF1A - NGS including CNV analysis Centogene AG - the Rare Disease Company Germany | 6 | 1 |
|
Genome-Nilou Lab Iran | 45 | 34 |
|
Labcorp Genetics (formerly Invitae) LabCorp United States | 210 | 134 |
|
Labcorp Genetics (formerly Invitae) LabCorp United States | 173 | 119 |
|
Invitae Monogenic Diabetes Panel Labcorp Genetics (formerly Invitae) LabCorp United States | 59 | 28 |
|
PreventionGenetics, part of Exact Sciences United States | 101 | 54 |
|
Hepatic adenoma, somatic, 142330 (HNF1A gene) (Sequence Analysis-All Coding Exons) (Postnatal) Intergen Intergen Genetics and Rare Diseases Diagnosis Center Turkey | 1 | 1 |
|
Labcorp Genetics (formerly Invitae) LabCorp United States | 409 | 164 |
|
Invitae 78 Gene Actionable Disorders Panel Labcorp Genetics (formerly Invitae) LabCorp United States | 220 | 75 |
|
Invitae Progressive Renal Disease Panel Labcorp Genetics (formerly Invitae) LabCorp United States | 310 | 195 |
|
Maturity-Onset Diabetes of the Young (MODY) Panel Ambry Genetics United States | 14 | 5 |
|
Dyslipidemia and early atherosclerosis panel. 84-gene NGS panel. Genologica Medica Spain | 133 | 84 |
|
MODY type diabetes panel. NGS panel of 13 genes. Genologica Medica Spain | 29 | 13 |
|
Comprehensive panel of monogenic diabetes. 28-gene NGS panel. Genologica Medica Spain | 60 | 28 |
|
Hypoglycemia, hyperinsulinism, and ketone metabolism panel. NGS panel of 50 genes. Genologica Medica Spain | 73 | 50 |
|
Comprehensive Metabolism NGS Panel Fulgent Genetics United States | 602 | 355 |
|
Fulgent Genetics United States | 71 | 53 |
|
Laboratorio de Genetica Clinica SL Spain | 1 | 1 |
|
IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.